Author

Diana P. Saraiva

Universidade Nova de LisboaORCID 0000-0002-7495-2288Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

António JacintoiD· 2 shared Bruna Filipa CorreiaiD· 2 shared D.S.C.P. Grosa· 2 shared Maria Guadalupe CabraliD· 2 shared Sofia Cristóvão‐FerreiraiD· 2 shared Telma MartinsiD· 2 shared Andreia Lopes· 1 shared Beatriz Martins· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

António JacintoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 24, 2026

CCR4+low-density neutrophils define a novel immunosuppressive subset associated with breast cancer progression and early mortality

Bruna Filipa Correia, D.S.C.P. Grosa, Rute Salvador…·Maria Guadalupe Cabral

The paper identifies a novel immunosuppressive neutrophil subset, CCR4+LDN, associated with breast cancer progression and mortality, and shows its potential as a biomarker and therapeutic target.

DOI 10.64898/2026.09.22.753474

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedSep 19, 2025

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer

Rute M. Salvador, Bruna Correia, D.S.C.P. Grosa…·Maria Guadalupe Cabral

This study shows that enhancing HLA-DR expression in cytotoxic T lymphocytes improves their anti-tumor activity, suggesting strategies to optimize adoptive T cell therapies for breast cancer.

5 citations

humanscRNA-seq

𝕏 PostBluesky